▶ 4:00 · $LLY · Lilly CEO: GLP-1 franchise targets 1B patients, R&D time halved, AI boosting manufacturing

episode briefing

David Ricks - CEO of Eli Lilly | Podcast | In Good Company | Norges Bank Investment Management

2025-02-19 · 2 company · 6 thematic

sentiment

2 bull0 bear0 neu

speakers

Nicolai Tangen is the CEO of Norges Bank Investment Management, which manages the Norwegian Sovereign Wealth Fund, one of the world's largest sovereign wealth funds. He hosts the podcast 'In Good Company' where he interviews leaders across various fields.

david ricks

CEO since 2021, 29-year company veteran, former head of China operations, board member of Adobe, engineer/MBA background.

quote

“I think we can easily say that weight management will become more like a choice than an Affliction and that's good we can also say that we've learned in the last 15 months that major categories of Downstream disease of obesity are affected…”

—david ricks

now playing · $LLY

$LLY···bullish· high· posnicolai tangen

Norges Bank CEO discloses $8B Lilly stake as GLP-1 leader

Sovereign wealth fund holds >1% position ($8B) in Eli Lilly as it spearheads weight-reducing drug revolution.

$LLY···bullish· highdavid ricks

Lilly CEO: GLP-1 franchise targets 1B patients, R&D time halved, AI boosting manufacturing

Tirzepatide and pipeline GLP-1s address obesity as choice not affliction with downstream benefits on cardiovascular, kidney, liver disease (40% of healthcare costs) and addiction;…

←